EMA public stakeholder meeting COVID 19 - How are COVID 19 vaccines developed Published 2020-12-14 Download video MP4 360p Recommendations 39:47 prj240611 S3 Efficacy endpoints in oncology 30:24 prj240611 S1 Overview of EMA-approved anti-cancer products 17:06 EMA public stakeholder meeting COVID 19 - EU’s regulatory process for evaluation and approval 1:29:13 Product Management Service (PMS) Product UI training (access & navigation) 1:56:10 Sunlight: Optimize Health and Immunity (Light Therapy and Melatonin) 56:53 Updated CAPs in web-based eAF information and Q&A session 1:25:09 Webinar Pilot to provide Scientific Advice to manufactures on certain high risk Medical Devices 33:56 EMA LinkedIn Live session on psychedelics and their therapeutic use 44:38 The Autism Connections - Alexis Quinn | MaxiAspie 1:02:57 APACMed White Paper Launch Webinar - Advancing Patient Access to NGS for Cancer in APAC 42:19 prj240611 EMA HMA Pilot Educational Program Oncology G4 1:30:20 UNICOM US Webinar May22 2024 1:00:36 How can health technology assessment contribute to quality of care? 03:42 One Health in Action: How EU Agencies are Tackling Environmental and Public Health Together 1:02:55 Oxford Biodynamics Plc HY results webinar: June 2024 56:50 prj240611 G2 How does scientific advice work? 16:17 How to Cope with Rumination: Don't Feed the “Demon” (Default Mode Network) 44:04 prj240611 G1 Introduction: Overview of the regulation of medicines in Europe 08:35 Cancer Medicines Forum workshop - video of the Belgian Health minister 55:55 MPE/ALAN Webinar | EU HTA Similar videos 3:20:50 EMA public stakeholder meeting COVID 19 2:08:37 EMA public stakeholder meeting on COVID 19 vaccines and therapeutics in the EU 29:55 EMA Public stakeholder meeting: Update on approved and candidate COVID-19 vaccines in the EU 12:19 EMA public stakeholder meeting COVID 19 - Safety monitoring of COVID 19 vaccines 2:14:55 EMA Public stakeholder meeting on assessment, approval and roll-out of pandemic vaccines 18:40 EMA public stakeholder meeting on COVID 19 - Basis for the EU approval of new vaccines 13:40 EMA public stakeholder meeting on COVID 19 - How the safety of the new COVID 19 vaccines will be ass 15:05 EMA public stakeholder meeting: COVID-19 surveillance and vaccination coverage in the EU 23:53 EMA public stakeholder meeting: Update on approved and candidate COVID-19 vaccines and therapeutics 2:30:25 EMA Public stakeholder meeting on assessment, approval and roll-out of new pandemic vaccines in EU 13:37 EMA public stakeholder meeting on COVID 19 - The European Commission’s role in the authorisation pro 2:06:44 EMA public stakeholder meeting on the approval and roll out of COVID 19 vaccines in the EU 08:12 EMA public stakeholder meeting on COVID 19 - Ongoing actions for roll out vaccination at national le 2:23:01 EMA Public stakeholder meeting on approval, safety monitoring, impact of pandemic vaccines in the EU 05:16 EMA public stakeholder meeting COVID 19 - Transparency, engagement and communication 08:57 EMA Public stakeholder meeting: Transparency and publication of clinical data for COVID-19 vaccines 2:14:11 EMA public stakeholder meeting on vaccines and therapeutics in the EU 3:01:28 EMA: Development and authorisation of safe and effective COVID-19 vaccines in the EU More results